[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::56121651.png) @BPharmCatalyst BioPharmCatalyst

BioPharmCatalyst posts on X about watchlist, $tnxp, $srpt, $wint the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::56121651/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:interactions.svg)

- X Week XXXXXXX +129%
- X Month XXXXXXX +69%
- X Months XXXXXXX +50%
- X Year XXXXXXXXX -XX%

### Mentions: XX [#](/creator/twitter::56121651/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:posts_active.svg)

- X Week XX +19%
- X Month XX +6%
- X Months XXX +24%
- X Year XXX +73%

### Followers: XXXXXX [#](/creator/twitter::56121651/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:followers.svg)

- X Week XXXXXX +0.33%
- X Month XXXXXX +0.86%
- X Months XXXXXX +2.10%
- X Year XXXXXX +4.20%

### CreatorRank: XXXXXXX [#](/creator/twitter::56121651/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::56121651/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::56121651/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [exchanges](/list/exchanges)  XXXX% [currencies](/list/currencies)  XXXX%

**Social topic influence**
[watchlist](/topic/watchlist) #66, [$tnxp](/topic/$tnxp) #3, [$srpt](/topic/$srpt) 2.17%, [$wint](/topic/$wint) 2.17%, [$otlk](/topic/$otlk) #1, [$abeo](/topic/$abeo) 1.63%, [$arwr](/topic/$arwr) 1.63%, [$pmn](/topic/$pmn) 1.63%, [$grph](/topic/$grph) 1.09%, [$vnda](/topic/$vnda) #1

**Top accounts mentioned or mentioned by**
[@marketwirenews](/creator/undefined) [@yusufhameed](/creator/undefined) [@libraryinvestor](/creator/undefined) [@terpstrader1](/creator/undefined) [@jjnmeinlove](/creator/undefined) [@jewcypickle](/creator/undefined) [@ridgeviewtrim](/creator/undefined) [@oldnormanbates](/creator/undefined) [@amimami07683953](/creator/undefined) [@stewdomer](/creator/undefined) [@dianegracely](/creator/undefined) [@financestrategi](/creator/undefined) [@voice4662](/creator/undefined) [@gwandaraboy](/creator/undefined) [@_dolemite_](/creator/undefined)

**Top assets mentioned**
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Immunogen Inc (IMGN)](/topic/$imgn) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Byepix (EPIX)](/topic/$epix) [SuperRare (RARE)](/topic/$rare) [GSK plc (GSK)](/topic/$gsk) [AstraZeneca PLC (AZN)](/topic/$azn) [Geron Corp (GERN)](/topic/$gern) [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)](/topic/$teva) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold)
### Top Social Posts [#](/creator/twitter::56121651/posts)
---
Top posts by engagements in the last XX hours

"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next X Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944748119146586233) 2025-07-14 13:17:37 UTC 29.9K followers, 7379 engagements


"BioPharmCatalyst Weekly #Watchlist Key Phase X Catalysts for the Next X Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1939683693120913896) 2025-06-30 13:53:24 UTC 29.8K followers, 6357 engagements


"🎧 New Episode Alert On Biotech Bulls and Breakthroughs John Gagliano and Sheff break down: 🔹 Key biotech market trends 🔹 Catalyst-driven trading strategies 🔹 Small-cap opportunities"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944723047396909140) 2025-07-14 11:38:00 UTC 29.9K followers, 241.3K engagements


"$GLPG reported that its first quarter 2025 results show consistent revenues of 140.3M but a significant XX% surge in R&D expenses to 278M. Overall expenses (G&A S&M) rose XX% to 74.5M. This led to a net loss of 259.1M a stark contrast to Q1 2024's 99.2M profit. Operating loss widened by XXX% to 215.7M. The company is exploring divestiture of its cell therapy business but maintains strong CAR-T programs and a solid 3.1B cash balance. See More Pre-market Movers 👇 $CYCC $PALI $ANNX $ATHE $MNOV $THAR $PSTV $ATRA $RCKT"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1948360559826551181) 2025-07-24 12:32:10 UTC 29.9K followers, 4227 engagements


"$ABVX shares are halted following results that its 50mg obefazimod achieved XXXX% pooled placebo-adjusted clinical remission at X weeks in Phase X ABTECT induction trials for moderate-to-severe UC meeting all key secondary endpoints with favorable safety. Maintenance data is due 2Q 2026 ahead of planned NDA/MAA submissions in 2H 2026. The company also delayed 1H 2025 financial results from August XX to September X 2025. Preliminary cash and cash equivalents as of June XX 2025 were approximately $XXXX million (unaudited). See More Biotech Updates👇 $IOVA $REPL $PMN $QNTM $STRO $AMIX $ABVX"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1947761507086864534) 2025-07-22 20:51:45 UTC 29.9K followers, 4098 engagements


"BioPharmCatalyst Weekly #Watchlist January XX 2024: Key Regulatory Catalysts for the next X months $OPTN $ABEO $GERN $IMGN $IPVA $AKBA $ASND $ESPR $ORTX $IBRX $TEVA"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1746190616428695895) 2024-01-13 15:21:00 UTC 29.9K followers, 4930 engagements


"$MRK will acquire $VRNA for $XXX per ADS in a deal valued at approximately $XX billion securing full ownership of Veronas respiratory drug assets. See More Pre-market Movers 👇 $KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1942924985221161373) 2025-07-09 12:33:08 UTC 29.8K followers, 5773 engagements


"$WINT signed a $60M securities purchase agreement led by Build and Build Corp with the potential to raise a total of $200M to launch a BNB crypto treasury strategy. Subject to shareholder approval Windtree aims to become the first NASDAQ-listed company offering direct BNB token exposure. See More Pre-market Movers 👇 $WINT $SRPT $PRTC $RCKT $NUWE"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945821738761150765) 2025-07-17 12:23:48 UTC 29.9K followers, 4379 engagements


"$SONN announced a business combination with Rorschach I LLC to form Hyperliquid Strategies Inc (HSI) a crypto treasury company expected to hold $888M in assets including 12.6M HYPE tokens and $305M in cash. HSI will remain listed on Nasdaq with backing from top crypto investors. See More Pre-market Movers 👇 $RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944734466997428250) 2025-07-14 12:23:23 UTC 29.9K followers, 5116 engagements


"$ITOS to be acquired by Concentra Biosciences for $10.047/share in cash plus a CVR tied to net cash above $475M and potential asset sales; tender offer to begin by Aug X 2025. See More Pre-market Movers 👇 $PMN $HSDT $ZIMV $SABS $NCNA $AUTL $EVO"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1947270385721802761) 2025-07-21 12:20:13 UTC 29.9K followers, 6196 engagements


"$CLSD initiated a strategic review to explore options including asset sales partnerships or M&A to advance its SCS platform; Piper Sandler retained to lead the process. See More Biotech Updates👇 $WINT $SRPT $RCKT $FOLD $MBRX $CLSD $ICU"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945943063223734497) 2025-07-17 20:25:54 UTC 29.8K followers, 5561 engagements


"$ANGO issued FY2026 guidance with projected net sales of $305310M slightly above the $304.9M consensus. Adjusted EPS is expected to show a loss of $0.350.25 vs. a $XXXX loss consensus with the forecast reflecting a $46M tariff headwind based on current July 2025 trade policy expectations. See More Pre-market Movers 👇 $SXTP $ADAG $OSTX $SLS $PMN"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945097855569404203) 2025-07-15 12:27:21 UTC 29.9K followers, 4812 engagements


"Want more info analysis and biotech news straight to your inbox Sign up for our FREE Daily and Weekly newsletters here:"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1945600565678879123) 2025-07-16 21:44:57 UTC 29.9K followers, 1416 engagements


"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next X Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1944023489872003526) 2025-07-12 13:18:12 UTC 29.9K followers, 7306 engagements


"Biotech updates 08/23: $GSK +ve anti-BCMA multiple myeloma data $EPIX offering +26% $SEEL offering -XX% $TENX data 1Q 2020 +6% $HEB - $AIM Pipeline updates $INCY $ZSAN"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1165049832613875712) 2019-08-23 23:55:00 UTC 29.8K followers, XX engagements


"$PMN shares closed up after the company announced that PMN310 its lead therapeutic candidate for Alzheimer's received FDA Fast Track designation. See More Biotech Updates👇 $PMN $ZIMV $EVO $SABS $HOOK $SLRX $CLSD $GDTC"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1947400894212886643) 2025-07-21 20:58:48 UTC 29.9K followers, 2395 engagements


"Biotech updates 07/10: $AMRX lowers profit forecast -XX% $OHRP holders approve merger +15% $SNSS offering -XX% $EYEN offering -XX% (-6% AH) $NBIX opicapone PDUFA 4/26/20 $SNY Isatuximab PDUFA 4/30/20 Pipeline updates $GSK $HZNP $LGND $MRK $SNDX"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1149062457115025408) 2019-07-10 21:06:52 UTC 29.8K followers, XX engagements


"BioPharmCatalyst updates 06/21/21: $TARS eyelash mite infestation data -XX% $ARWR collab +5% $CTXR +15%; $AVXL +14%; $SAVA +13% $NTEC -17%; $APVO -14%; $MLND -XX% Pipeline updates $AGIO $ANEB $AVXL $IMMP $INBX $MBRX $NXTC $OYST $RGLS $SRRA $TBPH $TNXP"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1407090667260579841) 2021-06-21 21:38:52 UTC 29.9K followers, XX engagements


"BioPharmCatalyst updates 02/25/21: $PAND acquired by MRK +133% $SRPT FDA Approval $ASLN private placement +27% $NVCR trial delays -XX% $TCDA -XX% AH Pipeline updates $AKBA $ASLN $ASMB $CARA $CMRX $EIDX $GKOS $ICPT $NVCR $REGN $YMAB $ZGNX"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1365086626855100417) 2021-02-25 23:49:48 UTC 29.9K followers, XX engagements


"BioPharmCatalyst Weekly #Watchlist Key Catalysts Due in Mid-2025 $REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1946585823467717081) 2025-07-19 15:00:00 UTC 29.9K followers, 6965 engagements


"Biotech updates 08/02: $GLYC fail -XX% AH $ACOR earnings -XX% $STML earnings +14% $CHRS earnings +18% $OASM leaving NASDAQ Pipeline updates $DCPH $IMGN $MNTA"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1157435677274857472) 2019-08-02 23:39:04 UTC 29.9K followers, XX engagements


"$TELO reported promising data for Telomir-1 which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1946183417592152183) 2025-07-18 12:20:59 UTC 29.9K followers, 2537 engagements


"$MIST received a new PDUFA date of Dec XX 2025 for CARDAMYST nasal spray for PSVT after FDA accepted its CRL resubmission. The company also extended its $75M royalty deal with RTW through year-end. Separately Milestone priced a $52.5M public offering of common and pre-funded warrants at $1.50/share expected to close July XX 2025. See More Biotech Updates👇 $NCNA $INKT $MIST $CAPR $JUNS $PHVS $DARE"  
![@BPharmCatalyst Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::56121651.png) [@BPharmCatalyst](/creator/x/BPharmCatalyst) on [X](/post/tweet/1943766321692336191) 2025-07-11 20:16:19 UTC 29.8K followers, 6185 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BPharmCatalyst BioPharmCatalyst

BioPharmCatalyst posts on X about watchlist, $tnxp, $srpt, $wint the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

X Week XXXXXXX +129%
X Month XXXXXXX +69%
X Months XXXXXXX +50%
X Year XXXXXXXXX -XX%

Mentions: XX #

X Week XX +19%
X Month XX +6%
X Months XXX +24%
X Year XXX +73%

Followers: XXXXXX #

X Week XXXXXX +0.33%
X Month XXXXXX +0.86%
X Months XXXXXX +2.10%
X Year XXXXXX +4.20%

CreatorRank: XXXXXXX #

Social Influence #

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX% exchanges XXXX% currencies XXXX%

Social topic influence watchlist #66, $tnxp #3, $srpt 2.17%, $wint 2.17%, $otlk #1, $abeo 1.63%, $arwr 1.63%, $pmn 1.63%, $grph 1.09%, $vnda #1

Top accounts mentioned or mentioned by @marketwirenews @yusufhameed @libraryinvestor @terpstrader1 @jjnmeinlove @jewcypickle @ridgeviewtrim @oldnormanbates @amimami07683953 @stewdomer @dianegracely @financestrategi @voice4662 @gwandaraboy @dolemite

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Arrowhead Research Corporation (ARWR) Cytokinetics Inc. (CYTK) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Immunogen Inc (IMGN) Merck & Co., Inc. (MRK) Byepix (EPIX) SuperRare (RARE) GSK plc (GSK) AstraZeneca PLC (AZN) Geron Corp (GERN) ImmunityBio, Inc. Common Stock (IBRX) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Amicus Therapeutics, Inc (FOLD)

Top Social Posts #

Top posts by engagements in the last XX hours

"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next X Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"
@BPharmCatalyst on X 2025-07-14 13:17:37 UTC 29.9K followers, 7379 engagements

"BioPharmCatalyst Weekly #Watchlist Key Phase X Catalysts for the Next X Months $ZYNE $PRAX $KPTI $AZN $DBVT $BTAI $AVBP $ABVX $XOMA $ENSC"
@BPharmCatalyst on X 2025-06-30 13:53:24 UTC 29.8K followers, 6357 engagements

"🎧 New Episode Alert On Biotech Bulls and Breakthroughs John Gagliano and Sheff break down: 🔹 Key biotech market trends 🔹 Catalyst-driven trading strategies 🔹 Small-cap opportunities"
@BPharmCatalyst on X 2025-07-14 11:38:00 UTC 29.9K followers, 241.3K engagements

"$GLPG reported that its first quarter 2025 results show consistent revenues of 140.3M but a significant XX% surge in R&D expenses to 278M. Overall expenses (G&A S&M) rose XX% to 74.5M. This led to a net loss of 259.1M a stark contrast to Q1 2024's 99.2M profit. Operating loss widened by XXX% to 215.7M. The company is exploring divestiture of its cell therapy business but maintains strong CAR-T programs and a solid 3.1B cash balance. See More Pre-market Movers 👇 $CYCC $PALI $ANNX $ATHE $MNOV $THAR $PSTV $ATRA $RCKT"
@BPharmCatalyst on X 2025-07-24 12:32:10 UTC 29.9K followers, 4227 engagements

"$ABVX shares are halted following results that its 50mg obefazimod achieved XXXX% pooled placebo-adjusted clinical remission at X weeks in Phase X ABTECT induction trials for moderate-to-severe UC meeting all key secondary endpoints with favorable safety. Maintenance data is due 2Q 2026 ahead of planned NDA/MAA submissions in 2H 2026. The company also delayed 1H 2025 financial results from August XX to September X 2025. Preliminary cash and cash equivalents as of June XX 2025 were approximately $XXXX million (unaudited). See More Biotech Updates👇 $IOVA $REPL $PMN $QNTM $STRO $AMIX $ABVX"
@BPharmCatalyst on X 2025-07-22 20:51:45 UTC 29.9K followers, 4098 engagements

"BioPharmCatalyst Weekly #Watchlist January XX 2024: Key Regulatory Catalysts for the next X months $OPTN $ABEO $GERN $IMGN $IPVA $AKBA $ASND $ESPR $ORTX $IBRX $TEVA"
@BPharmCatalyst on X 2024-01-13 15:21:00 UTC 29.9K followers, 4930 engagements

"$MRK will acquire $VRNA for $XXX per ADS in a deal valued at approximately $XX billion securing full ownership of Veronas respiratory drug assets. See More Pre-market Movers 👇 $KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA"
@BPharmCatalyst on X 2025-07-09 12:33:08 UTC 29.8K followers, 5773 engagements

"$WINT signed a $60M securities purchase agreement led by Build and Build Corp with the potential to raise a total of $200M to launch a BNB crypto treasury strategy. Subject to shareholder approval Windtree aims to become the first NASDAQ-listed company offering direct BNB token exposure. See More Pre-market Movers 👇 $WINT $SRPT $PRTC $RCKT $NUWE"
@BPharmCatalyst on X 2025-07-17 12:23:48 UTC 29.9K followers, 4379 engagements

"$SONN announced a business combination with Rorschach I LLC to form Hyperliquid Strategies Inc (HSI) a crypto treasury company expected to hold $888M in assets including 12.6M HYPE tokens and $305M in cash. HSI will remain listed on Nasdaq with backing from top crypto investors. See More Pre-market Movers 👇 $RANI $CELC $RARE $PRQR $IPA $EPIX $MGRM"
@BPharmCatalyst on X 2025-07-14 12:23:23 UTC 29.9K followers, 5116 engagements

"$ITOS to be acquired by Concentra Biosciences for $10.047/share in cash plus a CVR tied to net cash above $475M and potential asset sales; tender offer to begin by Aug X 2025. See More Pre-market Movers 👇 $PMN $HSDT $ZIMV $SABS $NCNA $AUTL $EVO"
@BPharmCatalyst on X 2025-07-21 12:20:13 UTC 29.9K followers, 6196 engagements

"$CLSD initiated a strategic review to explore options including asset sales partnerships or M&A to advance its SCS platform; Piper Sandler retained to lead the process. See More Biotech Updates👇 $WINT $SRPT $RCKT $FOLD $MBRX $CLSD $ICU"
@BPharmCatalyst on X 2025-07-17 20:25:54 UTC 29.8K followers, 5561 engagements

"$ANGO issued FY2026 guidance with projected net sales of $305310M slightly above the $304.9M consensus. Adjusted EPS is expected to show a loss of $0.350.25 vs. a $XXXX loss consensus with the forecast reflecting a $46M tariff headwind based on current July 2025 trade policy expectations. See More Pre-market Movers 👇 $SXTP $ADAG $OSTX $SLS $PMN"
@BPharmCatalyst on X 2025-07-15 12:27:21 UTC 29.9K followers, 4812 engagements

"Want more info analysis and biotech news straight to your inbox Sign up for our FREE Daily and Weekly newsletters here:"
@BPharmCatalyst on X 2025-07-16 21:44:57 UTC 29.9K followers, 1416 engagements

"Biotech updates 08/23: $GSK +ve anti-BCMA multiple myeloma data $EPIX offering +26% $SEEL offering -XX% $TENX data 1Q 2020 +6% $HEB - $AIM Pipeline updates $INCY $ZSAN"
@BPharmCatalyst on X 2019-08-23 23:55:00 UTC 29.8K followers, XX engagements

"$PMN shares closed up after the company announced that PMN310 its lead therapeutic candidate for Alzheimer's received FDA Fast Track designation. See More Biotech Updates👇 $PMN $ZIMV $EVO $SABS $HOOK $SLRX $CLSD $GDTC"
@BPharmCatalyst on X 2025-07-21 20:58:48 UTC 29.9K followers, 2395 engagements

"Biotech updates 07/10: $AMRX lowers profit forecast -XX% $OHRP holders approve merger +15% $SNSS offering -XX% $EYEN offering -XX% (-6% AH) $NBIX opicapone PDUFA 4/26/20 $SNY Isatuximab PDUFA 4/30/20 Pipeline updates $GSK $HZNP $LGND $MRK $SNDX"
@BPharmCatalyst on X 2019-07-10 21:06:52 UTC 29.8K followers, XX engagements

"BioPharmCatalyst updates 06/21/21: $TARS eyelash mite infestation data -XX% $ARWR collab +5% $CTXR +15%; $AVXL +14%; $SAVA +13% $NTEC -17%; $APVO -14%; $MLND -XX% Pipeline updates $AGIO $ANEB $AVXL $IMMP $INBX $MBRX $NXTC $OYST $RGLS $SRRA $TBPH $TNXP"
@BPharmCatalyst on X 2021-06-21 21:38:52 UTC 29.9K followers, XX engagements

"BioPharmCatalyst updates 02/25/21: $PAND acquired by MRK +133% $SRPT FDA Approval $ASLN private placement +27% $NVCR trial delays -XX% $TCDA -XX% AH Pipeline updates $AKBA $ASLN $ASMB $CARA $CMRX $EIDX $GKOS $ICPT $NVCR $REGN $YMAB $ZGNX"
@BPharmCatalyst on X 2021-02-25 23:49:48 UTC 29.9K followers, XX engagements

"BioPharmCatalyst Weekly #Watchlist Key Catalysts Due in Mid-2025 $REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX"
@BPharmCatalyst on X 2025-07-19 15:00:00 UTC 29.9K followers, 6965 engagements

"Biotech updates 08/02: $GLYC fail -XX% AH $ACOR earnings -XX% $STML earnings +14% $CHRS earnings +18% $OASM leaving NASDAQ Pipeline updates $DCPH $IMGN $MNTA"
@BPharmCatalyst on X 2019-08-02 23:39:04 UTC 29.9K followers, XX engagements

"$TELO reported promising data for Telomir-1 which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN"
@BPharmCatalyst on X 2025-07-18 12:20:59 UTC 29.9K followers, 2537 engagements

"$MIST received a new PDUFA date of Dec XX 2025 for CARDAMYST nasal spray for PSVT after FDA accepted its CRL resubmission. The company also extended its $75M royalty deal with RTW through year-end. Separately Milestone priced a $52.5M public offering of common and pre-funded warrants at $1.50/share expected to close July XX 2025. See More Biotech Updates👇 $NCNA $INKT $MIST $CAPR $JUNS $PHVS $DARE"
@BPharmCatalyst on X 2025-07-11 20:16:19 UTC 29.8K followers, 6185 engagements